Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Name: Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
License: Public Domain

AbbVie

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

rheumatoid-arthritis

rheumatoid arthritis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230322
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.